BSE Live
Mar 09, 16:01Prev. Close
4847.60
Open Price
4781.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 09, 15:56Prev. Close
4849.50
Open Price
4790.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
4769.50 (20)
| Key Financial Ratios of Pfizer (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 21.93 | 74.01 | 168.63 | 56.78 | 68.69 | |
| Diluted EPS (Rs.) | 21.93 | 74.01 | 168.63 | 56.78 | 68.69 | |
| Cash EPS (Rs.) | 43.91 | 76.68 | 171.30 | 65.06 | 79.86 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 431.26 | 220.62 | 567.77 | 437.18 | 389.85 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 431.26 | 220.62 | 567.77 | 437.18 | 389.85 | |
| Dividend / Share(Rs.) | 12.50 | 360.00 | 32.50 | 12.50 | 16.50 | |
| Revenue from Operations/Share (Rs.) | 405.10 | 372.55 | 351.86 | 367.07 | 419.68 | |
| PBDIT/Share (Rs.) | 98.43 | 116.58 | 97.96 | 96.96 | 121.34 | |
| PBIT/Share (Rs.) | 69.78 | 113.91 | 95.27 | 93.76 | 117.32 | |
| PBT/Share (Rs.) | 52.03 | 113.79 | 232.47 | 93.00 | 115.48 | |
| Net Profit/Share (Rs.) | 15.26 | 74.01 | 168.61 | 61.86 | 75.84 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 24.29 | 31.29 | 27.83 | 26.41 | 28.91 | |
| PBIT Margin (%) | 17.22 | 30.57 | 27.07 | 25.54 | 27.95 | |
| PBT Margin (%) | 12.84 | 30.54 | 66.06 | 25.33 | 27.51 | |
| Net Profit Margin (%) | 3.76 | 19.86 | 47.92 | 16.85 | 18.07 | |
| Return on Networth / Equity (%) | 3.53 | 33.54 | 29.69 | 14.14 | 19.45 | |
| Return on Capital Employed (%) | 3.48 | 32.76 | 29.45 | 13.87 | 18.89 | |
| Return on Assets (%) | 2.67 | 23.89 | 24.43 | 11.71 | 16.32 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 70.96 | 120.28 | 50.98 | 69.48 | 90.34 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.07 | 2.74 | 5.14 | 5.41 | 6.22 | |
| Quick Ratio (X) | 1.43 | 2.13 | 4.67 | 4.67 | 5.38 | |
| Inventory Turnover Ratio (X) | 4.78 | 7.34 | 6.36 | 5.98 | 7.86 | |
| Dividend Payout Ratio (NP) (%) | 81.90 | 486.41 | 19.27 | 20.20 | 21.75 | |
| Dividend Payout Ratio (CP) (%) | 28.46 | 469.47 | 18.97 | 19.21 | 20.65 | |
| Earnings Retention Ratio (%) | 18.10 | -386.41 | 80.73 | 79.80 | 78.25 | |
| Cash Earnings Retention Ratio (%) | 71.54 | -369.47 | 81.03 | 80.79 | 79.35 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 9,596.95 | 3,465.13 | 1,730.74 | 2,719.69 | 3,077.18 | |
| EV/Net Operating Revenue (X) | 5.18 | 3.12 | 1.65 | 2.48 | 2.46 | |
| EV/EBITDA (X) | 21.31 | 9.96 | 5.92 | 9.40 | 8.50 | |
| MarketCap/Net Operating Revenue (X) | 5.51 | 3.39 | 3.01 | 3.27 | 2.92 | |
| Retention Ratios (%) | 18.09 | -386.41 | 80.72 | 79.79 | 78.24 | |
| Price/BV (X) | 5.17 | 5.73 | 1.87 | 2.75 | 3.14 | |
| Price/Net Operating Revenue | 5.51 | 3.39 | 3.01 | 3.27 | 2.92 | |
| Earnings Yield | 0.01 | 0.06 | 0.16 | 0.05 | 0.06 |
10.02.2026
Pfizer Standalone December 2025 Net Sales at Rs 645.03 crore, up 19.9% Y-o-Y
13.11.2025
Pfizer Standalone September 2025 Net Sales at Rs 642.34 crore, up 9.13% Y-o-Y
20.05.2025
Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y
01.02.2025
Pfizer Standalone December 2024 Net Sales at Rs 537.99 crore, down 0.37% Y-o-Y
19.10.2016
05.08.2016
03.01.2014
10.01.2011